Oncology Journals

ESMO's flagship journal and one of the world's highest-impact oncology publications, publishing practice-changing clinical research, translational oncology, and ESMO Clinical Practice Guidelines. Covers all cancer types including breast cancer, gastrointestinal tumors, lung cancer, urogenital tumors, hematologic malignancies, head and neck cancer, sarcomas, and gynecologic cancers across phase I–III clinical trials.

ASCO's flagship journal and one of the world's highest-impact clinical oncology publications. Publishes practice-changing phase II/III clinical trials, systematic reviews, meta-analyses, and ASCO clinical practice guidelines across all cancer types. Covers novel therapeutic strategies, immunotherapy outcomes, biomarker-driven precision oncology, and oncology supportive care.

A high-impact open-access journal publishing research in hematology and oncology, including molecular mechanisms of hematologic and solid tumors, cancer immunotherapy, targeted therapies, CAR-T cell therapy, clinical trials, and review articles. Covers leukemia, lymphoma, myeloma, solid tumors, and the biology and treatment of all blood cancers and related malignancies.

A high-impact open-access journal covering molecular aspects of cancer biology, including cancer epigenetics, non-coding RNA, exosomes, tumor microenvironment, cancer immunotherapy, cancer metabolism, and therapeutic resistance mechanisms. Publishes research integrating molecular biology, genomics, and translational cancer science with clinical relevance.

AACR's flagship journal publishing impactful original studies, reviews, and opinion pieces of high significance to the broad cancer research community. Focuses on manuscripts offering conceptual or technological advances leading to basic and translational insights into cancer biology, including tumor immunology, cancer metabolism, DNA damage and repair, oncogenes and tumor suppressors, metastasis, and cancer microenvironment.

Covers all aspects of leukemia research from basic science including molecular biology, genomics, proteomics, stem cells, oncogenes, signal transduction, and hematopoiesis, to translational and clinical research. Publishes measurable residual disease (MRD) studies, targeted therapies, immune therapies, consensus statements, clinical practice guidelines, and high-impact clinical trials in hematologic malignancies.

An AACR journal dedicated to the interface of cancer biology and immunology, publishing research on tumor immunology, cancer immunotherapy, immune checkpoint biology, cancer vaccines, tumor-infiltrating immune cells, cancer immune evasion mechanisms, bispecific antibodies, CAR-T cells, and the immunological effects of conventional cancer therapies.

An AACR journal where the clinical insight is the central contribution. Publishes clinical and translational cancer research including early-phase clinical trials, biomarker studies, pharmacokinetics and pharmacodynamics in cancer patients, mechanisms of tumor sensitivity and resistance in clinical context, cancer imaging studies, and correlative science studies that link laboratory findings to clinical outcomes.

Publishes original research on cancer biology, cancer pharmacology, cancer mechanisms, and translational oncology. Covers tumor development, progression and metastasis, signal transduction in cancer, cancer drug action and resistance mechanisms, non-coding RNA in cancer, exosomes, cancer microenvironment, epigenetics, and cancer stem cells.

A Nature Partner Journal dedicated to precision oncology, publishing research on genomic and molecular profiling of tumors, cancer biomarker discovery, tumor heterogeneity, cancer drug sensitivity and resistance in context of molecular profiles, patient-derived models, real-world precision oncology outcomes, rare cancer responders, and clinical implementation of precision cancer medicine.

Focuses on the molecular basis of cancer development, covering oncogene and tumor suppressor function, signal transduction in cancer, cancer cell cycle regulation, cancer genetics and genomics, epigenetic cancer mechanisms, cancer metabolism, cancer immunology, and the molecular basis of drug resistance. Publishes high-impact original research and reviews on all aspects of molecular oncology.

One of the most cited general cancer journals, publishing cutting-edge discovery, translational, and clinical cancer research across all cancer types. Focuses on cancer metastasis, tumor microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of drug resistance, clinical trials, genomics, epigenomics, precision medicine, epidemiology, and cancer metabolism.

An open-access journal bridging experimental and clinical cancer research, publishing high-quality research on cancer cell biology, molecular mechanisms of cancer, cancer drug evaluation, tumor microenvironment, cancer immunology, cancer genomics, and translational studies with potential clinical impact. Covers all cancer types with emphasis on actionable mechanistic findings.

An open-access oncology journal covering all aspects of cancer research including cancer cell biology, cancer genetics, cancer pharmacology, and cancer therapeutics. Publishes research on molecular mechanisms of oncogenesis, cancer biomarkers, novel therapeutic targets, preclinical drug evaluation, and translational oncology. Note: indexed in Scopus and PubMed; not currently in Clarivate Web of Science SCIE.

Official journal of the Union for International Cancer Control (UICC), covering all aspects of oncology from basic science to clinical research with a global perspective. Focuses on cancer biology, tumor immunology, cancer epidemiology, molecular pathology, cancer genetics, biomarkers of diagnosis and prognosis, and novel therapeutic approaches across all cancer types.

An open-access journal covering all aspects of cancer research including cancer cell biology, molecular oncology, tumor microenvironment, cancer imaging, cancer preclinical models, cancer pharmacology, and translational research. Emphasizes mechanistic studies on neoplastic transformation, tumor progression, invasion, metastasis, and cancer therapeutics using in vitro and in vivo models.

Dedicated to all aspects of lung cancer research including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) biology, epidemiology, staging, pathology, genomic profiling, targeted therapy, immunotherapy, surgical treatment, radiation, chemotherapy, and clinical trials. Covers EGFR, ALK, ROS1, KRAS mutations and emerging biomarkers and resistance mechanisms.

Covers all aspects of gynecologic oncology including ovarian cancer, cervical cancer, endometrial cancer, vulvar cancer, and gestational trophoblastic neoplasia. Publishes clinical trials, translational research, surgical oncology outcomes, fertility-sparing approaches, molecular pathology, biomarker studies, and novel therapeutic approaches in gynecologic malignancies.

An MDPI open-access multidisciplinary journal covering all aspects of cancer research including cancer biology, molecular oncology, cancer epidemiology, cancer diagnostics and imaging, surgical oncology, radiation oncology, systemic therapies, immunotherapy, precision oncology, palliative care, and cancer survivorship. Particularly strong for multidisciplinary cancer reviews and rapid dissemination of cancer research.

An open-access journal dedicated to translational oncology research that bridges the gap between laboratory discoveries and clinical cancer care. Covers cancer biomarker development, cancer pharmacology, patient-derived cancer models, cancer genomics and transcriptomics in translational context, early clinical trials, and research linking molecular cancer mechanisms to therapeutic strategies and patient outcomes.

An open-access journal publishing original cancer research including cancer biology, cancer epidemiology, cancer prevention, clinical oncology, cancer genetics, cancer genomics, cancer immunology, translational research, and health services research in oncology. Covers all cancer types and accepts a range of article formats from original research to case reports and systematic reviews.

A dedicated breast cancer journal publishing original research on breast cancer biology, epidemiology, prevention, diagnosis, surgical treatment, radiation therapy, systemic therapy, breast cancer genomics, hormone receptor biology, HER2-positive breast cancer, triple-negative breast cancer, metastatic breast cancer, and breast cancer survivorship.

Covers all aspects of cancer biology and therapeutic development, including molecular mechanisms of cancer, novel anticancer drug discovery, targeted therapy, cancer signaling pathways, non-coding RNA in cancer, cancer epigenetics, cancer immunology, drug resistance mechanisms, and preclinical and clinical evaluation of new cancer therapies.

A dedicated prostate cancer and prostate biology journal covering the pathophysiology, molecular biology, epidemiology, diagnosis, and treatment of prostate cancer and benign prostatic hyperplasia (BPH). Topics include androgen receptor biology, prostate cancer genomics, prostate-specific antigen (PSA) biology, prostate cancer biomarkers, hormonal therapy, castration-resistant prostate cancer (CRPC), and prostate cancer clinical trials.

Focuses on the pharmacology of anticancer agents, covering mechanism of action, pharmacokinetics, drug metabolism, toxicology, and clinical evaluation of chemotherapy agents. Publishes research on drug resistance mechanisms, combination chemotherapy strategies, novel drug formulations, biomarkers of drug response, and preclinical evaluation of new anticancer compounds.

One of the oldest oncology journals (established 1903), publishing original research on cancer biology, tumor pathology, clinical oncology, experimental therapeutics, and translational research. Covers cancer molecular biology, tumor immunology, cancer epidemiology, surgical oncology, targeted therapies, and chemotherapy across all cancer types.

A peer-reviewed open-access journal covering basic, translational, and clinical cancer research across all cancer types. Publishes original articles, case reports, and reviews on cancer epidemiology, pathology, diagnostics, surgery, radiation, medical oncology, targeted therapy, immunotherapy, palliative care, and health outcomes research.

Dedicated to melanoma research covering all aspects of melanoma biology, epidemiology, pathology, diagnosis, surgical treatment, systemic therapy, immunotherapy, targeted therapy, and translational science. Topics include BRAF and MEK inhibitor therapy, checkpoint immunotherapy, melanoma genomics, tumor microenvironment, melanoma biomarkers, and melanoma clinical trials.

Publishes research on pharmacological and clinical aspects of established and novel anticancer compounds, including natural and synthetic compounds, biologics, and drug delivery systems. Covers mechanism of action studies, drug resistance, structure-activity relationships of anticancer agents, preclinical and early clinical investigations, and combination therapy.

Publishes original research on all aspects of clinical and experimental oncology, including cancer biology, cancer genetics, clinical oncology, cancer diagnostics, oncology therapeutics, and oncology case reports. Coverage includes all cancer types and oncology subspecialties, from basic molecular research to clinical outcomes.